The World Health Organization (WHO) has recently published a policy paper bringing together the available knowledge around existing traceability systems with the aim to support national regulatory authorities in setting up and ensuring an efficient traceability of medical products.
A strong system able to trace medicines in real-time along the supply chain will have a positive impact on the early detection of falsified and substandard medicines, allowing also for appropriate responses. If implemented the right way it can minimise the risk of fake medicines entering the supply chains.
Fight the Fakes welcomes the Policy paper on traceability of medical products and encourages Member States to use this guiding document in their efforts to safeguard patient safety from the threats of falsified and substandard medicines.
